Having trouble accessing articles? Reset your cache.

CMS broadens coverage of CAR T therapies

After receiving 146 comments across two comment periods, CMS has opened up its coverage criteria for CAR Ts.

In a final National Coverage Determination issued Wednesday, the Centers for Medicare & Medicaid

Read the full 315 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE